These results indicate that CSF1R small-molecule inhibitors target CD14-expressing monocytes in the CLL microenvironment, thereby depriving leukemia cells of extrinsic support signals. The gene discussed is CSF1R; the disease is B-cell chronic lymphocytic leukemia.